microRNAs in the Antitumor Immune Response and in Bone Metastasis of Breast Cancer: From Biological Mechanisms to Therapeutics

Breast cancer is the most common type of cancer in women, and the occurrence of metastasis drastically worsens the prognosis and reduces overall survival. Understanding the biological mechanisms that regulate the transformation of malignant cells, the consequent metastatic transformation, and the im...

Full description

Bibliographic Details
Main Authors: Marta Gomarasca, Paola Maroni, Giuseppe Banfi, Giovanni Lombardi
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/21/8/2805
_version_ 1797570336699449344
author Marta Gomarasca
Paola Maroni
Giuseppe Banfi
Giovanni Lombardi
author_facet Marta Gomarasca
Paola Maroni
Giuseppe Banfi
Giovanni Lombardi
author_sort Marta Gomarasca
collection DOAJ
description Breast cancer is the most common type of cancer in women, and the occurrence of metastasis drastically worsens the prognosis and reduces overall survival. Understanding the biological mechanisms that regulate the transformation of malignant cells, the consequent metastatic transformation, and the immune surveillance in the tumor progression would contribute to the development of more effective and targeted treatments. In this context, microRNAs (miRNAs) have proven to be key regulators of the tumor-immune cells crosstalk for the hijack of the immunosurveillance to promote tumor cells immune escape and cancer progression, as well as modulators of the metastasis formation process, ranging from the preparation of the metastatic site to the transformation into the migrating phenotype of tumor cells. In particular, their deregulated expression has been linked to the aberrant expression of oncogenes and tumor suppressor genes to promote tumorigenesis. This review aims at summarizing the role and functions of miRNAs involved in antitumor immune response and in the metastasis formation process in breast cancer. Additionally, miRNAs are promising targets for gene therapy as their modulation has the potential to support or inhibit specific mechanisms to negatively affect tumorigenesis. With this perspective, the most recent strategies developed for miRNA-based therapeutics are illustrated.
first_indexed 2024-03-10T20:24:27Z
format Article
id doaj.art-b91621a7c9d940c59ee8a40cad1971fe
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T20:24:27Z
publishDate 2020-04-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-b91621a7c9d940c59ee8a40cad1971fe2023-11-19T21:56:40ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672020-04-01218280510.3390/ijms21082805microRNAs in the Antitumor Immune Response and in Bone Metastasis of Breast Cancer: From Biological Mechanisms to TherapeuticsMarta Gomarasca0Paola Maroni1Giuseppe Banfi2Giovanni Lombardi3Laboratory of Experimental Biochemistry & Molecular Biology, IRCCS Istituto Ortopedico Galeazzi, 20161 Milano, ItalyLaboratory of Experimental Biochemistry & Molecular Biology, IRCCS Istituto Ortopedico Galeazzi, 20161 Milano, ItalyLaboratory of Experimental Biochemistry & Molecular Biology, IRCCS Istituto Ortopedico Galeazzi, 20161 Milano, ItalyLaboratory of Experimental Biochemistry & Molecular Biology, IRCCS Istituto Ortopedico Galeazzi, 20161 Milano, ItalyBreast cancer is the most common type of cancer in women, and the occurrence of metastasis drastically worsens the prognosis and reduces overall survival. Understanding the biological mechanisms that regulate the transformation of malignant cells, the consequent metastatic transformation, and the immune surveillance in the tumor progression would contribute to the development of more effective and targeted treatments. In this context, microRNAs (miRNAs) have proven to be key regulators of the tumor-immune cells crosstalk for the hijack of the immunosurveillance to promote tumor cells immune escape and cancer progression, as well as modulators of the metastasis formation process, ranging from the preparation of the metastatic site to the transformation into the migrating phenotype of tumor cells. In particular, their deregulated expression has been linked to the aberrant expression of oncogenes and tumor suppressor genes to promote tumorigenesis. This review aims at summarizing the role and functions of miRNAs involved in antitumor immune response and in the metastasis formation process in breast cancer. Additionally, miRNAs are promising targets for gene therapy as their modulation has the potential to support or inhibit specific mechanisms to negatively affect tumorigenesis. With this perspective, the most recent strategies developed for miRNA-based therapeutics are illustrated.https://www.mdpi.com/1422-0067/21/8/2805breast cancerbone metastasesmiRNAsNK cellsimmune evasionmiRNA-based therapeutics
spellingShingle Marta Gomarasca
Paola Maroni
Giuseppe Banfi
Giovanni Lombardi
microRNAs in the Antitumor Immune Response and in Bone Metastasis of Breast Cancer: From Biological Mechanisms to Therapeutics
International Journal of Molecular Sciences
breast cancer
bone metastases
miRNAs
NK cells
immune evasion
miRNA-based therapeutics
title microRNAs in the Antitumor Immune Response and in Bone Metastasis of Breast Cancer: From Biological Mechanisms to Therapeutics
title_full microRNAs in the Antitumor Immune Response and in Bone Metastasis of Breast Cancer: From Biological Mechanisms to Therapeutics
title_fullStr microRNAs in the Antitumor Immune Response and in Bone Metastasis of Breast Cancer: From Biological Mechanisms to Therapeutics
title_full_unstemmed microRNAs in the Antitumor Immune Response and in Bone Metastasis of Breast Cancer: From Biological Mechanisms to Therapeutics
title_short microRNAs in the Antitumor Immune Response and in Bone Metastasis of Breast Cancer: From Biological Mechanisms to Therapeutics
title_sort micrornas in the antitumor immune response and in bone metastasis of breast cancer from biological mechanisms to therapeutics
topic breast cancer
bone metastases
miRNAs
NK cells
immune evasion
miRNA-based therapeutics
url https://www.mdpi.com/1422-0067/21/8/2805
work_keys_str_mv AT martagomarasca micrornasintheantitumorimmuneresponseandinbonemetastasisofbreastcancerfrombiologicalmechanismstotherapeutics
AT paolamaroni micrornasintheantitumorimmuneresponseandinbonemetastasisofbreastcancerfrombiologicalmechanismstotherapeutics
AT giuseppebanfi micrornasintheantitumorimmuneresponseandinbonemetastasisofbreastcancerfrombiologicalmechanismstotherapeutics
AT giovannilombardi micrornasintheantitumorimmuneresponseandinbonemetastasisofbreastcancerfrombiologicalmechanismstotherapeutics